Home Technology Acquisition Announcement Spurs LipoScience Surge

Acquisition Announcement Spurs LipoScience Surge

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

LipoScience Inc (NASDAQ:LPDX), Magnum Hunter Resources Corp (NYSE:MHR) and Corinthian Colleges Inc (NASDAQ:COCO) are today’s top-gaining billionaire stock picks midday. On the losing end are NII Holdings Inc (NASDAQ:NIHD), Cleco Corporation (NYSE:CNL) and Stemline Therapeutics Inc (NASDAQ:STML).

Sign Up For Our Free Newsletter

LipoScience Soars on News of Acquisition

LipoScience Inc (NASDAQ:LPDX) surged +62.54% today following news that it will be acquired by Laboratory Corp. of America Holdings (NYSE:LH) as part of an $85 million deal. Thanks to today’s jump, LPDX is currently trading just cents away from its 52-week high of $5.22. The diagnostic company has been in Wilbur Ross’ investment portfolio since Q1 2013.

[drizzle]

Magnum Hunter Resources Corp (NYSE:MHR) climbed +10.44% early in the day this Thursday following its production results announcement. The George Soros pick, an independent oil and gas company, has had a bit of a rough go in 2014, with its price down -17.31% year-to-date.

The share price of Corinthian Colleges Inc (NASDAQ:COCO) rallied +6.18%. One of the largest for-profit education companies in the U.S., Corinthian has had a terrible 2014, and on the market, it’s lost -93.44% YTD. It’s worth noting that Soros purchased 69,000 COCO shares in Q2.

Cleco Dips as Sale Efforts Falter

NII Holdings Inc (NASDAQ:NIHD) plunged -9.22% this morning, as the company’s stock price continues to suffer the consequences of its bankruptcy filing mid-month. It has declined nearly -100% YTD and more than -50% in the past 10 days.

Cleco Corporation (NYSE:CNL) fell -8.52% following reports that its efforts to find a buyer are faltering. The Louisiana-based electric utility company is a new Q2 pick for Farallon Capital, which purchased 39,000 shares. The fund is still waiting for returns on its investment, however, as CLN has declined -16.2% over the past three months.

Stemline Therapeutics Inc (NASDAQ:STML), also a Farallon holding, reached midday with a -6.21% loss. Its price has declined -40.22% year-to-date.

[/drizzle]
Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski5 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...